TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32056817

Group type: EXPERIMENTAL
Intervention: Pranayama breathing technique for 20 min once daily for 1 month
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relaxation technique, applied similarly to pranayama group
Number of subjects: 0
Study: 34645510

Group type: COMPARATOR
Intervention: Magill forceps (Group M)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tube core (Group T)
Number of subjects: 60
Study: 32442094

Group type: EXPERIMENTAL
Intervention: 0.5 minute ventilation (MV)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Minute ventilation (MV)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard fixed fresh gas flow technique (FGF = 6 L/min)
Number of subjects: 45
Study: 34237184

Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation (breathing, aerobic, posture, stretching, strengthening exercises under remote supervision via Internet for 3 days/week for 10 weeks)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Home exercise program (same exercises at home on their own with weekly calls)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation
Number of subjects: 122

Group type: COMPARATOR
Intervention: Home exercise program
Number of subjects: 122
Study: 33307785

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10/25 mg)
Number of subjects: 7020

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020
Study: 34047220

Group type: EXPERIMENTAL
Intervention: Emotion Regulation Therapy (ERT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 81
Study: 32919407

Group type: EXPERIMENTAL
Intervention: Eszopiclone (3 mg)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Coupled spindle-slow oscillation events
Number of subjects: 55
Study: 34982119

Group type: EXPERIMENTAL
Intervention: Tailored implementation strategies (3 sites, n=744 patients)
Number of subjects: 1436

Group type: COMPARATOR
Intervention: Education-only (control, 3 sites, n=692 patients)
Number of subjects: 1436

Group type: EXPERIMENTAL
Intervention: Tailored implementation strategies
Number of subjects: 1436

Group type: COMPARATOR
Intervention: Education-only (control)
Number of subjects: 1436
Study: 35251573

Group type: EXPERIMENTAL
Intervention: Home cardiac rehabilitation based on mobile medical technical guidance after discharge
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine home cardiac rehabilitation after discharge
Number of subjects: 60
Study: 35830754

Group type: EXPERIMENTAL
Intervention: Online Cognitive Behavioural Therapy (o-CBT)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Online Psychological Support (o-PS)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 207
Study: 33930706

Group type: EXPERIMENTAL
Intervention: Favipiravir
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (standard care alone)
Number of subjects: 55
Study: 32861904

Group type: EXPERIMENTAL
Intervention: Mini-open pedicle screw (MPS) fixation with Wiltse approach
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluoroscopic-guided percutaneous pedicle screw (PPS) placement
Number of subjects: 60
Study: 33459181

Group type: EXPERIMENTAL
Intervention: CDCA (13-16 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: UDCA (12-16 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No BA (control)
Number of subjects: 12
Study: 32458473

Group type: EXPERIMENTAL
Intervention: Group CBT
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 130
Study: 35445820

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day
Number of subjects: 4304

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4304
Study: 32544914

Group type: EXPERIMENTAL
Intervention: Lutein plus DHA group (LT/DHA-G)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lutein group (LT-G)
Number of subjects: 100
Study: 33070770

Group type: EXPERIMENTAL
Intervention: Betamethasone (12 mg/kg/BW twice, intramuscularly)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no betamethasone)
Number of subjects: 140
Study: 35578170

Group type: EXPERIMENTAL
Intervention: Low tidal volume (VT) ventilation
Number of subjects: 1206

Group type: COMPARATOR
Intervention: Conventional VT ventilation
Number of subjects: 1206
Study: 34346586

Group type: EXPERIMENTAL
Intervention: Proton therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MRI-guided radiotherapy
Number of subjects: 0
Study: 34866026

Group type: EXPERIMENTAL
Intervention: NiTi coil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Elastomeric chains
Number of subjects: 20
Study: 34367634

Group type: EXPERIMENTAL
Intervention: Platelet Rich Fibrin (PRF) combined with autologous microlobular fat
Number of subjects: 18

Group type: COMPARATOR
Intervention: Autologous microlobular fat alone
Number of subjects: 18
Study: 35332849

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 4
Study: 34230503

Group type: EXPERIMENTAL
Intervention: HD-tDCS (2.4 mA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Conventional tDCS (2.0 mA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham tDCS (2.0 mA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control condition (TTE1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control condition (TTE2)
Number of subjects: 12
Study: 32393387

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 0.125 M l-glutamic acid
Number of subjects: 399

Group type: COMPARATOR
Intervention: Saline (1.65 mL/kg of body weight per hour)
Number of subjects: 399
Study: 36395032

Group type: EXPERIMENTAL
Intervention: Homework engagement in ICBT
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder (GAD-7) assessments
Number of subjects: 301
Study: 34391308

Group type: EXPERIMENTAL
Intervention: Yoga intervention (3 sessions per week for 3 months)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Waitlisted control
Number of subjects: 96
Study: 32265253

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt‐PA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy (EVT)
Number of subjects: 0
Study: 34820724

Group type: EXPERIMENTAL
Intervention: CAF + CTG-ACEJ
Number of subjects: 38

Group type: COMPARATOR
Intervention: CAF + CTG-CEJ
Number of subjects: 38
Study: 35770548

Group type: EXPERIMENTAL
Intervention: Preoperative acupuncture (GA)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Postoperative acupuncture (GPA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Meloxicam (GM)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Overall comparison
Number of subjects: 36
Study: 33484221

Group type: EXPERIMENTAL
Intervention: Kidney Optimal Health Program (psychosocial intervention, nine sessions)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 84
Study: 36184252

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (3 × 10^10 of probiotic capsules containing nine Lactobacillus and five Bifidobacterium species)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32544117

Group type: EXPERIMENTAL
Intervention: Application of a long‐acting cyanoacrylate skin protectant (durable, ultra‐thin, transparent, waterproof, no‐removal barrier film)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 36
Study: 35775177

Group type: EXPERIMENTAL
Intervention: Oxidized zirconium (OxZr) femoral head with UHMWPE liner (Group C)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Cobalt-chrome (CoCr) femoral head with XLPE liner (Group A)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Oxidized zirconium (OxZr) femoral head with XLPE liner (Group B)
Number of subjects: 262
Study: 34057253

Group type: EXPERIMENTAL
Intervention: WeChat remote health education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Leaflet education
Number of subjects: 0
Study: 32781310

Group type: EXPERIMENTAL
Intervention: Subjective Opiate Withdrawal Scale (SOWS)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Clinical Opiate Withdrawal Scale (COWS)
Number of subjects: 103
Study: 33284480

Group type: EXPERIMENTAL
Intervention: Subcutaneous abatacept (weight-tiered doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous abatacept
Number of subjects: 0
Study: 35841189

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Medium dose of alcohol (MED)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High dose of alcohol (HIGH)
Number of subjects: 24
Study: 33565706

Group type: EXPERIMENTAL
Intervention: 10 g erythritol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 25 g erythritol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 g erythritol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Tap water enriched with 13C-sodium acetate (placebo)
Number of subjects: 12
Study: 32171721

Group type: EXPERIMENTAL
Intervention: 50 IU/kg rhC1INH before and 4 h after elective coronary angiography
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 33755176

Group type: EXPERIMENTAL
Intervention: Preemptive antiviral therapy (PET) with valganciclovir
Number of subjects: 79
Study: 33054890

Group type: COMPARATOR
Intervention: Iron and folic acid (IFA) - 60 mg/d Fe and 400 µg/d folic acid
Number of subjects: 1391

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MMN) - 18 vitamins and minerals including 250 µg/d iodine
Number of subjects: 1391

Group type: EXPERIMENTAL
Intervention: Small-quantity lipid-based nutrient supplements (LNS) - 20 g/d with similar nutrient contents as MMN
Number of subjects: 1391
Study: 33656415

Group type: EXPERIMENTAL
Intervention: Identification with story characters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Egocentric projection onto story characters
Number of subjects: 0
Study: 34973831

Group type: EXPERIMENTAL
Intervention: Invasive blood pressure monitoring (IBPM)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Non-invasive blood pressure monitoring (NIBPM)
Number of subjects: 126
Study: 33038081

Group type: EXPERIMENTAL
Intervention: 0.14 mm diameter DBNs
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.16 mm diameter DBNs
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.18 mm diameter DBNs
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.20 mm diameter DBNs
Number of subjects: 20

Group type: COMPARATOR
Intervention: All needle diameters
Number of subjects: 20
Study: 32690519

Group type: EXPERIMENTAL
Intervention: Person-centred care (PCC) by a combined digital platform and structured telephone support
Number of subjects: 0
Study: 36254015

Group type: EXPERIMENTAL
Intervention: Mobile applications (3 different types)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group (no mobile application)
Number of subjects: 320
Study: 33797490

Group type: EXPERIMENTAL
Intervention: D14 mSOFA score of 1 or less in ATB-202
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: D14 mSOFA score of 1 or less in ATB-204
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: D14 mSOFA score of 1 or less (combined analysis)
Number of subjects: 506
Study: 32357897

Group type: EXPERIMENTAL
Intervention: Alvarado Score-based management algorithm
Number of subjects: 160

Group type: COMPARATOR
Intervention: Current best practice
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: CT evaluation
Number of subjects: 160
Study: 616930567

Group type: EXPERIMENTAL
Intervention: HAS combined therapy with vinorelbine-based chemotherapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Vinorelbine-based standard chemotherapy
Number of subjects: 62
Study: 34124972

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for insomnia and pain (CBTi.p., N = 18)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Psychoeducation (N = 17)
Number of subjects: 35
Study: 33006763

Group type: EXPERIMENTAL
Intervention: Video‐based PA counseling intervention (Video-PA)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Active control (Video-C)
Number of subjects: 59
Study: 36054143

Group type: EXPERIMENTAL
Intervention: Moxifloxacin (800 mg/day for four days)
Number of subjects: 38
Study: 33844014

Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure Variability (SBPV)
Number of subjects: 1394

Group type: EXPERIMENTAL
Intervention: Pulse Pressure Variability (PPV)
Number of subjects: 1394

Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure Variability (DBPV)
Number of subjects: 1394

Group type: EXPERIMENTAL
Intervention: Mean Arterial Pressure Variability (MAPV)
Number of subjects: 1394
Study: 33028084

Group type: EXPERIMENTAL
Intervention: Adjuvant sunitinib (50 mg/day; 4 weeks on/2 weeks off)
Number of subjects: 609

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 609
Study: 33041039

Group type: EXPERIMENTAL
Intervention: 60 mL of 1:1 fish:flaxseed oil blend
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 60 mL of 1:1 fish:flaxseed oil blend with 200 mg of α‐tocopherol
Number of subjects: 180

Group type: COMPARATOR
Intervention: No supplement added to colostrum (control)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 180
Study: 35302412

Group type: EXPERIMENTAL
Intervention: Lateral decubitus position (LP group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Supine position (SP group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups (LP and SP)
Number of subjects: 90
Study: 34607865

Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 451
Study: 32384578

Group type: EXPERIMENTAL
Intervention: 4% RX0041-002
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: 8% RX0041-002
Number of subjects: 648

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 648
Study: 33954891

Group type: EXPERIMENTAL
Intervention: Web-based intervention for increasing physical activity and decreasing sedentary time
Number of subjects: 85

Group type: COMPARATOR
Intervention: Behavior 'as usual' wait-listed control
Number of subjects: 85
Study: 33741237

Group type: EXPERIMENTAL
Intervention: Amniotic membrane (test group; n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Split-thickness skin graft (control group; n = 25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Amniotic membrane (test group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Split-thickness skin graft (control group)
Number of subjects: 50
Study: 35968361

Group type: EXPERIMENTAL
Intervention: CX-DZ-II intelligent electronic stimulator
Number of subjects: 164

Group type: COMPARATOR
Intervention: SDZ-II regular electronic stimulator
Number of subjects: 164
Study: 33393104

Group type: EXPERIMENTAL
Intervention: Foot care protocol
Number of subjects: 57
Study: 35778935

Group type: EXPERIMENTAL
Intervention: Chitosan dressing
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nanosilver dressing
Number of subjects: 25
Study: 34613358

Group type: EXPERIMENTAL
Intervention: Vasopressin and steroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32229443

Group type: EXPERIMENTAL
Intervention: 50 g/day flaxseed flour with meals (n=60)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 15 mL/day of a lactulose solution on an empty stomach (n=30)
Number of subjects: 90
Study: 35168620

Group type: EXPERIMENTAL
Intervention: Talonavicular joint mobilization (TJM)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Blended intervention
Number of subjects: 48
Study: 32791641

Group type: EXPERIMENTAL
Intervention: Impulse-radio ultra-wideband (IR-UWB) radar technology
Number of subjects: 79

Group type: COMPARATOR
Intervention: Micromovement sensitive mattress (MSM) and IR-UWB
Number of subjects: 79
Study: 35765085

Group type: EXPERIMENTAL
Intervention: Topically applied allogeneic cellular product containing CD362 enriched mesenchymal stem cells suspended in a collagen solution
Number of subjects: 2
Study: 33315763

Group type: EXPERIMENTAL
Intervention: Clazakizumab (high-affinity anti-IL-6 antibody)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Belatacept
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD38 antibodies
Number of subjects: 0
Study: 33077559

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT) dressing, n=224
Number of subjects: 448

Group type: COMPARATOR
Intervention: Non-NPWT dressing, n=224
Number of subjects: 448
Study: 35912152

Group type: EXPERIMENTAL
Intervention: Postauricular injection of methylprednisolone sodium succinate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (conventional treatment)
Number of subjects: 60
Study: 33226000

Group type: EXPERIMENTAL
Intervention: Intervention-guided strategy plus optimal medical therapy (OMT)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT) alone
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Intervention-guided strategy plus OMT
Number of subjects: 251
Study: 32912323

Group type: EXPERIMENTAL
Intervention: Basic assisted feedback (22 homes, 69 care units)
Number of subjects: 8766

Group type: EXPERIMENTAL
Intervention: Enhanced assisted feedback 2 (23 homes, 72 care units)
Number of subjects: 8766

Group type: COMPARATOR
Intervention: Simple feedback (control group)
Number of subjects: 8766
Study: 35297385

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate administration in the French dataset (1234 patients, 450 matched)
Number of subjects: 54787

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate administration in the North-American dataset (4902 patients, 1238 matched)
Number of subjects: 54787
Study: 35730613

Group type: EXPERIMENTAL
Intervention: Behavioral weight-loss intervention
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Fecal butyrate increase
Number of subjects: 121
Study: 32217792

Group type: EXPERIMENTAL
Intervention: US-MR image fusion navigation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fluoroscopy
Number of subjects: 20
Study: 34983199

Group type: EXPERIMENTAL
Intervention: Employer EBI implementation
Number of subjects: 63
Study: 33667721

Group type: EXPERIMENTAL
Intervention: Healthy and Ready to Learn (HRL) status
Number of subjects: 7565

Group type: COMPARATOR
Intervention: Sociodemographic factors
Number of subjects: 7565

Group type: COMPARATOR
Intervention: Health, family, and neighborhood factors
Number of subjects: 7565

Group type: COMPARATOR
Intervention: State-level HRL prevalence
Number of subjects: 7565
Study: 32585585

Group type: EXPERIMENTAL
Intervention: drinks/week
Number of subjects: 1500000

Group type: EXPERIMENTAL
Intervention: alcohol use disorder (AUD)
Number of subjects: 1500000

Group type: EXPERIMENTAL
Intervention: age-adjusted alcohol use disorder identification test (AUDIT-C)
Number of subjects: 1500000
Study: 34269634

Group type: EXPERIMENTAL
Intervention: Peer-facilitated PADs
Number of subjects: 72

Group type: COMPARATOR
Intervention: Non-peer clinician-facilitated PADs
Number of subjects: 72
Study: 34848523

Group type: EXPERIMENTAL
Intervention: Oestradiol cypionate intramuscular (IM) and micronised progesterone oral (PO), in addition to standard of care (SOC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo, in addition to standard of care (SOC)
Number of subjects: 120
Study: 34856196

Group type: EXPERIMENTAL
Intervention: Deep neural ulcerative colitis (DNUC) system for real-time histological assessment
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Deep neural ulcerative colitis (DNUC) for endoscopic scoring
Number of subjects: 770
Study: 33824248

Group type: EXPERIMENTAL
Intervention: Biphenyl dimethyl dicarboxylate/ursodeoxycholic acid
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 35059786

Group type: EXPERIMENTAL
Intervention: Low protein diet (8%) + 600 mg kg-1 curcumin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normal protein diet (19%)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Low protein diet (8%)
Number of subjects: 36
Study: 32465257

Group type: EXPERIMENTAL
Intervention: Era 2 (October 2018 - June 2019)
Number of subjects: 25820

Group type: COMPARATOR
Intervention: Era 1 (January 2006 - September 2018)
Number of subjects: 25820
Study: 34288114

Group type: EXPERIMENTAL
Intervention: First-line ASCT (n = 20)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Second-line ASCT (n = 48, following BEAM)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Third/fourth-line ASCT (n = 8)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Second-line ASCT with low-risk FLIPI at relapse
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Second-line ASCT with intermediate-risk FLIPI at relapse
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Second-line ASCT with high-risk FLIPI at relapse
Number of subjects: 76
Study: 33272365

Group type: EXPERIMENTAL
Intervention: Triglycerides (per 10 mg/dl)
Number of subjects: 6901

Group type: EXPERIMENTAL
Intervention: Non-HDL-C (per 10 mg/dl)
Number of subjects: 6901

Group type: EXPERIMENTAL
Intervention: Remnant-C (per 10 mg/dl)
Number of subjects: 6901

Group type: EXPERIMENTAL
Intervention: Atherogenic dyslipidemia (triglycerides >150 mg/dl and HDL-C <40 mg/dl in men or <50 mg/dl in women)
Number of subjects: 6901

Group type: EXPERIMENTAL
Intervention: Remnant-C ≥30 mg/dl
Number of subjects: 6901
Study: 35102669

Group type: EXPERIMENTAL
Intervention: Polychromatic short-wavelength-enriched light
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dim, red ambient light (control)
Number of subjects: 12
Study: 33049701

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Number of subjects: 45
Study: 32634068

Group type: EXPERIMENTAL
Intervention: Intravenous chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oral chemotherapy
Number of subjects: 90
Study: 35671067

Group type: EXPERIMENTAL
Intervention: Hypothermic Oxygenated Perfusion (HOPE)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Static Cold Storage (SCS)
Number of subjects: 110
Study: 34388615

Group type: EXPERIMENTAL
Intervention: Virtual disaster simulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Live disaster simulation
Number of subjects: 0
Study: 35373585

Group type: EXPERIMENTAL
Intervention: Bosentan (125 mg, twice per day for 3 days)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33109706

Group type: EXPERIMENTAL
Intervention: Edaravone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo-Edaravone arm
Number of subjects: 0